For all media enquiries please email us on media@melanoma.org.au
MIA researchers on Highly Cited 2021 List
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.
Skin surveillance saves lives from melanoma
New research shows routine skin checks by a health professional, plus checking your own skin, are vital in saving lives from melanoma.
Game On Mole – saving lives this summer
COVID lockdowns may have deterred patients seeking medical treatment, making our 'Game On Mole' campaign more important than ever.
A paradigm shift in melanoma treatment
Drug therapy looks set to become the standard treatment for high-risk early stage melanoma patients.
Melanoma Bike Bash 2021: What a ride!
Over two fun, yet challenging, days on the weekend of 18 & 19 September an intrepid group of 22 riders and 10 hardworking volunteer crew successfully completed the 160km annual Melanoma Bike Bash in WA!
Prof Georgina Long AO awarded AAHMS Medal
“The future looks bright – I truly believe that we will get to zero deaths from melanoma with the trajectory we’re following.”
Community Fundraising Wrap Up Apr-June 2021
Read more about our incredible community fundraisers and the many ways they are helping us reach zero deaths from melanoma.
Amie St Clair Ball in Wagga postponed again
The 10th anniversary Amie St Clair Ball, the major annual fundraiser for melanoma services in the Riverina, has been postponed for the 3rd time due to COVID restrictions.
Honouring Ben’s life by supporting the next generation of melanoma researchers
The Garrow family honour their dearly loved family member Ben with the Ben Garrow PhD Scholarship.
MIA’s Annual Research Retreat 2021
The Retreat shared highlights from MIA-led research activities. Despite COVID research has continued unabated.
Queen’s Birthday Honour for Professor Richard Scolyer
Prof Scolyer has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine.
Successful trial of new immunotherapy treatment
Successful trial of a new immunotherapy drug which offers a third, and less toxic, option for the treatment of advanced melanoma.
Suzanne Sherwood says:
Steve Cole says:
Catherine Mardell says: